30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
HeFRA
Extensive Post-discharge Counselling and Phone-based Follow-up Intervention to Reduce Heart Failure Readmission- A Pilot Randomized Control Trial
1 other identifier
interventional
150
1 country
1
Brief Summary
In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Jul 2025
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2025
CompletedStudy Start
First participant enrolled
July 14, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedAugust 3, 2025
July 1, 2025
9 months
July 1, 2025
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-day and 90-day heart failure readmissions between the intervention group and the control group.
30-day and 90-day heart failure readmissions between the intervention group and the control group.
90 days
Study Arms (2)
control/Usual Care
NO INTERVENTIONThe usual care (counselling by their attending physicians and their normal outpatient reviews).
intervention arm
EXPERIMENTALInterventions
Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90.
Eligibility Criteria
You may qualify if:
- · Adults Aged 18 years and above
- Diagnosed with heart failure
- NYHA Class II-IV
- Informed consent
You may not qualify if:
- · NHYA class I
- Patients who do not have access to a mobile phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Komfo Anokye Teaching Hospital
Kumasi, Ashanti Region, Ghana
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2025
First Posted
August 3, 2025
Study Start
July 14, 2025
Primary Completion
March 31, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
August 3, 2025
Record last verified: 2025-07